Pan Drugs Limited - Company Profile

It is a pharma public limited company based in Vadodara, Gujarat, India, established in 1993.
1993 Vadodara, Gujarat, India Active
Last Updated:
Access Report
About Pan Drugs Limited

Pan Drugs Limited, a active public limited company, was established on 16 November 1993 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ1993PLC020671. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.50 Cr and a paid-up capital of ₹3.14 Cr.

It upholds a compliant status. Employing 34 professional, Its leadership includes Atul Natwarlal Pandya (Director), Parag Vamanray Raval (Director), Kamal Natwarlal Pandya (Director). Past directors included Sudhirkumar Anantprakash Dhingra, Atul Natwarlal Pandya, Kashmira Atulbhai Pandya. It holds ₹2.84 M open charges and ₹45.08 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 301,312 World Trade Center, Sayajigunj, Vadodara, Gujarat, 390007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ1993PLC020671

  • Registration Number

    020671

  • Incorporation Date

    16 November 1993

  • Authorized Capital

    ₹5.50 Cr

  • Paid-Up Capital

    ₹3.14 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.50 Cr
  • Paid Up Capital ₹ 3.14 Cr
  • Company Age 32 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.84 M
  • Satisfied Charges ₹ 45.08 Cr
  • Revenue Growth **** -18.99%
  • Profit Growth **** 2162.05%
  • Ebitda **** -72.78%
  • Net Worth 191.08%
  • Total Assets -36.75%
Company report

Pan Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pan Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pan Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Atul Natwarlal Pandya Director 31 Jul 2007 Current
Parag Vamanray Raval Director 10 May 2018 Current
Kamal Natwarlal Pandya Director 16 Nov 1993 Current
Hemant Gajanand Upadhyay Director 31 May 2003 Current
Rushiraj Atulbhai Pandya Additional Director 10 Mar 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Jul 2015 Past
Pramod Abcsdd Additional Director 29 Sep 2007 Past
Pramod Abcsdd Director 23 Feb 2018 Past
Pramod Abcsdd Cfo(Kmp) - Past
Pramod Abcsdd Director 24 Feb 2018 Past
Pramod Abcsdd Director 24 Feb 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pan Drugs.

Pan Drugs Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.99% decrease. The company also saw a substantial improvement in profitability, with a 2162.05% increase in profit. The company's net worth Soared by an impressive increase of 191.08%.

Pan Drugs revenue growth over time
Pan Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -18.99%
*******
*******
*******
*******
Revenue from Operations
*******
 -40.46%
*******
*******
*******
*******
Total Assets
*******
 -36.75%
*******
*******
*******
*******
Profit or Loss
*******
 2162.05%
*******
*******
*******
*******
Net Worth
*******
 191.08%
*******
*******
*******
*******
EBITDA
*******
 -72.78%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pan Drugs?

In 2023, Pan Drugs had a promoter holding of 43.56% and a public holding of 56.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,842,702.00

Satisfied Charges

₹450,800,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.28 Cr
Latest Charge Details
Date Lender Amount Status
31 Dec 2021 Hdfc Bank Limited ₹2.84 M Open
20 Oct 2001 State Band Of Hydrabad ₹3.00 Cr Satisfied
13 Sep 2000 Anyonya Co - Operative Bank Ltd. ₹1.00 Cr Satisfied
31 Mar 2000 Idbi Bank Ltd. ₹11.00 Cr Satisfied
03 Dec 1999 Idbi Bank Ltd. ₹8.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Pan Drugs?

Pan Drugs has a workforce of 34 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pan Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pan Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pan Drugs
Recent Activity within the Organization
  • Director Appointment

    The activity Rushiraj Atulbhai Pandya was appointed as a Additional Director was appointed as a Additional Director on 10 Mar 2025 & has been associated with this company since 11 months 14 days . was completed.

  • Annual General Meeting

    The activity Pan Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Pan Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.28 Cr with Charge ID 100527683 was registered on 31 Dec 2021. was documented.

  • Charges

    Progress on A charge registered on 13 Sep 2000 via Charge ID 90099257 with Anyonya Co - Operative Bank Ltd. was fully satisfied on 23 Jan 2020. was documented.

  • Charges

    The activity A charge registered on 15 Oct 1998 via Charge ID 90096565 with Anyonya Sahakari Mandli Co - Op. Bank Ltd. was fully satisfied on 23 Jan 2020. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pan Drugs Limited?

The CIN of Pan Drugs Limited is U24230GJ1993PLC020671.

Where is Pan Drugs Limited headquartered?

Pan Drugs Limited is headquartered at 301,312 World Trade Center, Sayajigunj, Vadodara, Gujarat, 390007.

When was Pan Drugs Limited incorporated?

Pan Drugs Limited was incorporated on 16 November 1993.

Who are the current directors of Pan Drugs Limited?

The current directors of Pan Drugs Limited are

What is the primary industry of Pan Drugs Limited?

The primary industry of Pan Drugs Limited is Manufacturing.

Is Pan Drugs Limited a listed company?

Pan Drugs Limited is unlisted.

What is the capital structure of Pan Drugs Limited?

The authorized capital of Pan Drugs Limited is ₹5.50 Cr, and the paid-up capital is ₹3.14 Cr.

What is the compliance status of Pan Drugs Limited?

The compliance status of Pan Drugs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available